Genetic testing and insurance

L. Andrews, B. B. Biesecker, N. Fost, L. G. Jackson, Nancy E Kass, J. A. Lowden, T. H. Murray, J. Payne, P. R. Reilly, M. A. Rothstein

Research output: Contribution to journalArticle

Abstract

The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?

Original languageEnglish (US)
Pages (from-to)327-331
Number of pages5
JournalAmerican Journal of Human Genetics
Volume56
Issue number1
StatePublished - 1995

Fingerprint

Genetic Testing
Insurance
Health Services Accessibility
Reality Testing
Insurance Carriers
Public Policy
Medical Records
Delivery of Health Care

ASJC Scopus subject areas

  • Genetics

Cite this

Andrews, L., Biesecker, B. B., Fost, N., Jackson, L. G., Kass, N. E., Lowden, J. A., ... Rothstein, M. A. (1995). Genetic testing and insurance. American Journal of Human Genetics, 56(1), 327-331.

Genetic testing and insurance. / Andrews, L.; Biesecker, B. B.; Fost, N.; Jackson, L. G.; Kass, Nancy E; Lowden, J. A.; Murray, T. H.; Payne, J.; Reilly, P. R.; Rothstein, M. A.

In: American Journal of Human Genetics, Vol. 56, No. 1, 1995, p. 327-331.

Research output: Contribution to journalArticle

Andrews, L, Biesecker, BB, Fost, N, Jackson, LG, Kass, NE, Lowden, JA, Murray, TH, Payne, J, Reilly, PR & Rothstein, MA 1995, 'Genetic testing and insurance', American Journal of Human Genetics, vol. 56, no. 1, pp. 327-331.
Andrews L, Biesecker BB, Fost N, Jackson LG, Kass NE, Lowden JA et al. Genetic testing and insurance. American Journal of Human Genetics. 1995;56(1):327-331.
Andrews, L. ; Biesecker, B. B. ; Fost, N. ; Jackson, L. G. ; Kass, Nancy E ; Lowden, J. A. ; Murray, T. H. ; Payne, J. ; Reilly, P. R. ; Rothstein, M. A. / Genetic testing and insurance. In: American Journal of Human Genetics. 1995 ; Vol. 56, No. 1. pp. 327-331.
@article{bb9211cef1c94d1288c04518da3f6eca,
title = "Genetic testing and insurance",
abstract = "The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?",
author = "L. Andrews and Biesecker, {B. B.} and N. Fost and Jackson, {L. G.} and Kass, {Nancy E} and Lowden, {J. A.} and Murray, {T. H.} and J. Payne and Reilly, {P. R.} and Rothstein, {M. A.}",
year = "1995",
language = "English (US)",
volume = "56",
pages = "327--331",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Genetic testing and insurance

AU - Andrews, L.

AU - Biesecker, B. B.

AU - Fost, N.

AU - Jackson, L. G.

AU - Kass, Nancy E

AU - Lowden, J. A.

AU - Murray, T. H.

AU - Payne, J.

AU - Reilly, P. R.

AU - Rothstein, M. A.

PY - 1995

Y1 - 1995

N2 - The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?

AB - The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented underwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist?

UR - http://www.scopus.com/inward/record.url?scp=0028813762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028813762&partnerID=8YFLogxK

M3 - Article

C2 - 7825594

AN - SCOPUS:0028813762

VL - 56

SP - 327

EP - 331

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -